CME Group (Nasdaq: CME), which operates a major US derivatives exchange , reported $1.1 billion in revenue for the fourth quarter of 2021, along with an operating income of $632 million. These figures jumped by 4.4 percent and 22.5 percent, respectively, on a yearly basis.
Announced on Wednesday, the platform detailed that the net income for the three months came in at $625 million, while the diluted earnings per share stood at $1.71. Both these figures came in at $608 million and $1.66, respectively, on an adjusted basis.
Interestingly, the revenue and EPS for the quarter came in line with the consensus street estimates.
The revenue for the full year came in at $4.7 billion and operating income at $2.6 billion. The net income for 12 months was at $2.6 billion, with diluted EPS at $7.29. The adjusted net income and EPS were at $2.4 billion and $6.67, respectively.
Trading Demand Surged
Additionally, the exchange provided the trading metrics, showcasing a solid jump in the institutional demand. The average daily volume (ADV) in the final quarter of the year increased by 26 percent year-over-year to 20.5 million contracts. In addition to that, Non-US ADV jumped by 4 percent to reach a record 5.5 million contracts.
Moreover, CME collected $949 million in clearing and transaction fees revenue in the quarter. It also generated $142 million in revenue from market data services.
“We achieved record trading volume in 2021, driven by client demand for tools to hedge against continued economic uncertainty across markets,” said Terry Duffy, the Chairman and CEO of CME Group. “We delivered strong performance across core benchmarks, new products and international business during 2021.”
“We are pleased 2022 is off to a strong start with our highest January average daily volume on record of 24.6 million contracts, led by strong equity index and interest rate volumes.”
